Sezary syndrome (SS), named after the French dermatologist Albert Sezary (1880–1956), is a variant of cutaneous T-cell lymphoma (CTCL), a malignancy of mature T-helper cells involving the skin and blood. It is defined by the presence of an exfoliative erythroderma (an inflammation of the skin with erythema and scales involving over 80 % of the body surface), lymphadenopathy, and evidence of neoplastic cells in the skin and blood. “Sezary” cells refer to enlarged mature CD4+ lymphocytes with hyperconvoluted nuclei. Historically, the presence of Sezary cells in the peripheral blood was a defining criterion for SS. However, an increased number of these cells can be found in several benign dermatologic conditions and is no longer the agreed-upon standard. The presence of a clonally expanded population of CD4+ cells resulting in an increased CD4/CD8 > 10 in the blood is considered a more accurate measure. Immunophenotypic abnormalities which support a diagnosis of SS include...
KeywordsAllogeneic Bone Marrow Allogeneic Bone Marrow Transplantation Dermatologic Condition Sezary Syndrome Nail Dystrophy
- Willemze R (2003) Cutaneous T-cell lymphoma. In: Bologna J, Jorizzo J, Rapini R (eds) Dermatology. Elsevier, Amsterdam, pp 1921–1961Google Scholar
- (2012) Exfoliative Erythroderma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1360. doi: 10.1007/978-3-642-16483-5_2057Google Scholar
- (2012) Extracorporeal Photochemotherapy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1366. doi: 10.1007/978-3-642-16483-5_2071Google Scholar
- (2012) Lichenification. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2034. doi: 10.1007/978-3-642-16483-5_3346Google Scholar